Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Forian Inc (FORA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/02/2025: FORA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $5
1 Year Target Price $5
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -39.38% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/02/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 61.47M USD | Price to earnings Ratio - | 1Y Target Price 5 |
Price to earnings Ratio - | 1Y Target Price 5 | ||
Volume (30-day avg) 1 | Beta 1.03 | 52 Weeks Range 1.85 - 4.03 | Updated Date 07/2/2025 |
52 Weeks Range 1.85 - 4.03 | Updated Date 07/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.12 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -16.5% | Operating Margin (TTM) -19.77% |
Management Effectiveness
Return on Assets (TTM) -7.24% | Return on Equity (TTM) -13.02% |
Valuation
Trailing PE - | Forward PE 39.37 | Enterprise Value 32576153 | Price to Sales(TTM) 2.75 |
Enterprise Value 32576153 | Price to Sales(TTM) 2.75 | ||
Enterprise Value to Revenue 1.46 | Enterprise Value to EBITDA 20.05 | Shares Outstanding 31202300 | Shares Floating 7687002 |
Shares Outstanding 31202300 | Shares Floating 7687002 | ||
Percent Insiders 56.08 | Percent Institutions 13.6 |
Upturn AI SWOT
Forian Inc
Company Overview
History and Background
Forian Inc., formerly Helix Technologies, Inc., focuses on providing technology and data-driven solutions to the cannabis and healthcare industries. They aim to optimize operational efficiencies and enhance decision-making for their clients.
Core Business Areas
- Data and Technology Solutions: Provides data analytics, software, and technology services to help cannabis and healthcare businesses improve operations and patient outcomes.
- Financial Services: Offers financial services and solutions tailored to the specific needs of the cannabis industry, including tax and compliance support.
Leadership and Structure
The leadership team comprises experienced executives in technology, data analytics, and finance. The organizational structure supports the company's focus on data-driven solutions and client services.
Top Products and Market Share
Key Offerings
- Basalt Platform: A data analytics platform for the cannabis industry, providing insights into sales, operations, and marketing. Market share data is unavailable in public sources. Competitors include BDSA, Headset, and New Frontier Data. This provides revenue generating insight for cannabis businesses.
- BioTrackTHC: Seed-to-sale tracking software for cannabis cultivators and dispensaries. Market share data is unavailable in public sources. Competitors include MJ Freeway, Flowhub, and Greenbits. BioTrackTHC aims to ensure compliance within the supply chain.
Market Dynamics
Industry Overview
The cannabis industry is experiencing rapid growth and increasing regulation. The market demands data-driven solutions to optimize operations and maintain compliance. The healthcare industry continues to embrace data and technology for improvements in outcomes and efficiency.
Positioning
Forian Inc. positions itself as a key provider of data and technology solutions in the cannabis and healthcare industries, offering tailored services to meet the unique needs of these sectors.
Total Addressable Market (TAM)
The TAM for data and technology solutions in the cannabis and healthcare industries is estimated to be in the billions of dollars. Forian Inc. aims to capture a significant portion of this market by offering specialized and integrated solutions.
Upturn SWOT Analysis
Strengths
- Specialized expertise in the cannabis and healthcare industries
- Data-driven solutions for operational optimization
- Strong relationships with clients in key markets
- Integrated platform offering a range of services
Weaknesses
- Limited brand recognition compared to larger competitors
- Relatively small size may limit resources for expansion
- Dependence on the regulatory environment of the cannabis industry
Opportunities
- Expanding into new geographic markets
- Developing new data analytics products
- Acquiring complementary businesses
- Growing demand for compliance solutions
Threats
- Increasing competition from larger companies
- Changes in cannabis regulations
- Economic downturn affecting client spending
- Data security breaches
Competitors and Market Share
Key Competitors
- CRON
- SMG
- TLRY
Competitive Landscape
Forian Inc. faces significant competition from larger and more established companies in the cannabis and healthcare technology sectors. Their advantage lies in their specialized expertise and tailored solutions.
Major Acquisitions
Medical Outcomes Research Institute
- Year: 2020
- Acquisition Price (USD millions): 1.8
- Strategic Rationale: Acquisition of Medical Outcomes Research Institute expanded Forian's data-driven healthcare capabilities.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data cannot be provided without access to detailed financial records.
Future Projections: Future growth projections are unavailable without analyst estimates or company guidance.
Recent Initiatives: Recent initiatives include expanding partnerships within the cannabis industry and enhancing the capabilities of the Basalt platform.
Summary
Forian Inc. is a smaller player in a rapidly growing market, offering niche data and technology solutions for the cannabis and healthcare industries. Its strength lies in its specialization, but it faces challenges from larger competitors and regulatory uncertainties. To succeed, Forian Inc. needs to focus on innovation, strategic partnerships, and expanding its market reach. Publicly traded, this company is speculative with potential for growth and should be watched.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC filings, Company press releases, Market research reports, Industry analysis reports, Corporate websites
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is based on estimates and may not be precise. Investment decisions should be based on thorough due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Forian Inc
Exchange NASDAQ | Headquaters Newtown, PA, United States | ||
IPO Launch date 2021-03-03 | Co-Founder, CEO, President & Executive Chairman of the Board Mr. Max C. Wygod | ||
Sector Healthcare | Industry Health Information Services | Full time employees 47 | Website https://forian.com |
Full time employees 47 | Website https://forian.com | ||
Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the life science, healthcare, and financial services industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions. The company's subscription and services-based solutions cover the life sciences, pharmaceutical services, healthcare payer, and provider and financial services industries. Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.